Actively Recruiting
Evaluating Muscle Response Monitor-Guided Atracurium Dosing Compared to Routine Care in ICU Patients Needing Continuous Muscle Relaxation
Led by Fu Jen Catholic University Hospital · Updated on 2026-09-08
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether using a muscle response monitor can lower the amount of atracurium, a muscle relaxant, needed in adults treated in an intensive care unit ICU who require a continuous infusion of this drug for more than 48 hours. This trial aims to compare dosing guided by the TwitchView electromyography-based train-of-four TOF monitor targeting moderate paralysis, to usual care guided by bedside clinical checks. The goal is to see if the monitored approach reduces drug use and complications while maintaining effective muscle relaxation. Participants will receive atracurium continuously as part of their ICU treatment for conditions such as moderate-to-severe acute respiratory distress syndrome ARDS, post-cardiac arrest care with targeted temperature management TTM, or extracorporeal membrane oxygenation ECMO support. Those in the intervention group will have a small sensor placed on their wrist and hand to measure muscle response with dosing adjusted to maintain a TOF count of 2 to 3. The control group will receive routine care based on clinical assessment. Infusion rates are adjusted regularly, with monitoring continuing for 72 hours. During the study, participants will be sedated to a specified sedation level and monitored closely by nurses and respiratory therapists who adjust the atracurium dose. Researchers will measure the cumulative dose and infusion rate over 72 hours, track paralysis adequacy, survival rates, ventilator dependence, adverse events, ICU-acquired weakness, and neurological outcomes. Participants will be observed until hospital discharge, with an expected enrollment of about 120 patients.
CONDITIONS
Brief Title
TwichView-guided Atricurium Dose Adjustment Trial
Research Team
H
Herman Chih-Heng Chang, M.D., M.M.S.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here